Determinants and causes of maternal mortality in Iran based on ICD-MM: a systematic review.


Journal

Reproductive health
ISSN: 1742-4755
Titre abrégé: Reprod Health
Pays: England
ID NLM: 101224380

Informations de publication

Date de publication:
08 Feb 2019
Historique:
received: 13 07 2018
accepted: 22 01 2019
entrez: 10 2 2019
pubmed: 10 2 2019
medline: 23 2 2019
Statut: epublish

Résumé

No systematic review has explored the causes of and factors associated with maternal mortality in the context of Iran. This study reviewed determinants and causes of maternal mortalities during pregnancy, delivery and the puerperium using the International Classification of Diseases-Maternal Mortality (ICD-MM), introduced by the World Health Organization. A systematic electronic search of all the studies that identified causes and/or determinants of maternal deaths in any part of Iran or in the whole country were included, without any restriction of time or language of studies. To identify the studies to include in this study, a combination of hand searching and bibliographies was also conducted. These sources and citations yielded a total of 653 articles; nevertheless, only 29 articles met the inclusion criteria, hence, required data were extracted, summarized, and grouped together from these papers and are reported in the tables. Amongst the 29 studies published between 2003 and 2017 in Iran, 24 studies were cross-sectional. Overall, 4633 deaths were reviewed, and 2655 (58%) of the cases included the data on the causes of death generally. According to the ICD-MM, a total of 69.9, 20.6, and 5.2% of the mortalities were due to direct, indirect and unspecified causes respectively and 4.3% of the causes were not clear in several studies. The leading direct and indirect causes of death were identified as hemorrhage (30.7%) and hypertensive disorders (17.1%) and circulatory system diseases (8.1%) respectively. Several factors including gravidity, type of delivery, socio-economic status of mothers, locations of birth, death and maternity care venues were found in the original studies as the most important determinant of maternal mortalities in Iran. This study, provided an updated summary of evidences on the causes and determinants of maternal death in Iran, which is critically important for the development of interventions and reduction of the burden of maternal mortality and morbidities.

Sections du résumé

BACKGROUND BACKGROUND
No systematic review has explored the causes of and factors associated with maternal mortality in the context of Iran. This study reviewed determinants and causes of maternal mortalities during pregnancy, delivery and the puerperium using the International Classification of Diseases-Maternal Mortality (ICD-MM), introduced by the World Health Organization.
METHODS METHODS
A systematic electronic search of all the studies that identified causes and/or determinants of maternal deaths in any part of Iran or in the whole country were included, without any restriction of time or language of studies. To identify the studies to include in this study, a combination of hand searching and bibliographies was also conducted. These sources and citations yielded a total of 653 articles; nevertheless, only 29 articles met the inclusion criteria, hence, required data were extracted, summarized, and grouped together from these papers and are reported in the tables.
RESULTS RESULTS
Amongst the 29 studies published between 2003 and 2017 in Iran, 24 studies were cross-sectional. Overall, 4633 deaths were reviewed, and 2655 (58%) of the cases included the data on the causes of death generally. According to the ICD-MM, a total of 69.9, 20.6, and 5.2% of the mortalities were due to direct, indirect and unspecified causes respectively and 4.3% of the causes were not clear in several studies. The leading direct and indirect causes of death were identified as hemorrhage (30.7%) and hypertensive disorders (17.1%) and circulatory system diseases (8.1%) respectively. Several factors including gravidity, type of delivery, socio-economic status of mothers, locations of birth, death and maternity care venues were found in the original studies as the most important determinant of maternal mortalities in Iran.
CONCLUSIONS CONCLUSIONS
This study, provided an updated summary of evidences on the causes and determinants of maternal death in Iran, which is critically important for the development of interventions and reduction of the burden of maternal mortality and morbidities.

Identifiants

pubmed: 30736803
doi: 10.1186/s12978-019-0676-y
pii: 10.1186/s12978-019-0676-y
pmc: PMC6368742
doi:

Types de publication

Journal Article Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

16

Références

Lancet. 2005 Mar 12-18;365(9463):997-1000
pubmed: 15767003
Burns. 2006 Mar;32(2):246-50
pubmed: 16448763
Lancet. 2006 Apr 1;367(9516):1066-1074
pubmed: 16581405
Lancet. 2006 Sep 30;368(9542):1189-200
pubmed: 17011946
Int J Gynaecol Obstet. 2010 Nov;111(2):152-6
pubmed: 20810108
Arch Iran Med. 2012 Jan;15(1):14-7
pubmed: 22208437
Int J Prev Med. 2012 Feb;3(2):116-21
pubmed: 22347608
Matern Child Health J. 2013 May;17(4):577-80
pubmed: 22618490
Singapore Med J. 2012 Oct;53(10):684-9
pubmed: 23112022
Int J Health Policy Manag. 2013 Oct 05;1(4):255-9
pubmed: 24596882
Lancet. 2014 Sep 13;384(9947):980-1004
pubmed: 24797575
Int J Surg. 2014 Dec;12(12):1495-9
pubmed: 25046131
Lancet Glob Health. 2014 Jun;2(6):e323-33
pubmed: 25103301
BJOG. 2014 Sep;121 Suppl 4:32-40
pubmed: 25236631
Epidemiol Health. 2014 Nov 08;36:e2014028
pubmed: 25381997
Iran J Public Health. 2014 Oct;43(10):1395-404
pubmed: 26060702
Lancet. 2016 Jan 30;387(10017):462-74
pubmed: 26584737
Electron Physician. 2016 Feb 25;8(2):1949-54
pubmed: 27054003
Lancet. 2016 May 21;387(10033):2072-2073
pubmed: 27301808
J Clin Diagn Res. 2016 Aug;10(8):QC14-7
pubmed: 27656510
J Family Reprod Health. 2016 Sep;10(3):154-162
pubmed: 28101117
Electron Physician. 2017 Jul 25;9(7):4914-4923
pubmed: 28894555
J Family Reprod Health. 2017 Mar;11(1):1-6
pubmed: 29114262
PLoS One. 2017 Dec 29;12(12):e0190285
pubmed: 29287102
J Obstet Gynaecol Br Commonw. 1970 Dec;77(12):1103-8
pubmed: 4321867

Auteurs

Rostam Zalvand (R)

Department of Health Management and Economics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.

Maryam Tajvar (M)

Department of Health Management and Economics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran. mtajvar@tums.ac.ir.

Abolghasem Pourreza (A)

Department of Health Management and Economics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.

Hadi Asheghi (H)

Department of Health Management and Economics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH